Search

Your search keyword '"Skalska-Sadowska, Jolanta"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Skalska-Sadowska, Jolanta" Remove constraint Author: "Skalska-Sadowska, Jolanta"
46 results on '"Skalska-Sadowska, Jolanta"'

Search Results

1. Late effects of childhood cancer treatment in long-term survivors diagnosed before the age of 3 years – A multicenter, nationwide study

3. Analysis of early and treatment related deaths among children and adolescents with acute myeloid leukemia in Poland: 2005–2023.

4. Treatment Outcomes of Adolescents Compared to Younger Pediatric Patients with Acute Myeloid Leukemia: Do They Need a Special Approach?

5. Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience

6. Cytogenetic findings in Polish patients with suspected Fanconi anemia.

7. Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia—Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022

8. Cytogenetic findings in Polish patients with suspected Fanconi anemia

11. Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children--the Polish Pediatric Leukemia and Lymphoma Study Group experience.

14. Pediatric Acute Myeloid Leukemia Post Cytotoxic Therapy—Retrospective Analysis of the Patients Treated in Poland from 2005 to 2022

15. Characteristics and treatment results of refractory and relapsed acute myeloid leukaemia in paediatric patients treated in Polish Paediatric Leukaemia/Lymphoma Study Group institutions according to the Protocol Acute Myeloid Leukaemia Berlin-Frankfurt-Munster 2012 and a review of novel treatment possibilities in paediatric acute myeloid leukaemia

16. Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group

17. Late Effects of Childhood Cancer Treatment in Long-Term Survivors Diagnosed Before the Age of 3 Years - A Multicenter, Nationwide Study

19. Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019

22. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland

23. Additional file 2 of Novel FANCA mutation in the first fully-diagnosed patient with Fanconi anemia in Polish population – case report

24. Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy

25. High Frequency of Fusion Gene Transcript Resulting From t(10;11)(p12;q23) Translocation in Pediatric Acute Myeloid Leukemia in Poland

26. Retrospective Analysis of the Treatment Outcome in Myeloid Leukemia of Down Syndrome in Polish Pediatric Leukemia and Lymphoma Study Group From 2005 to 2019

27. Treatment Outcome and the Genetic Characteristics of Acute Promyelocytic Leukemia in Children in Poland From 2005 to 2018

28. The influence of different intensity of treatment on hormonal markers of gonadal function in acute lymphoblastic leukemia survivors

29. Infections in children with acute myeloid leukemia: increased mortality in relapsed/refractory patients

30. Outcome of refractory and relapsed acute myeloid leukemia in children treated during 2005–2011 – experience of the Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG)

32. Treatment-related gonadotoxicity in young male cancer survivors: a comparative cross-sectional study

33. A newborn with congenital mixed phenotype acute leukemia with complex translocation t(10;11)(p12;q23) with KMT2A/MLLT10 rearranged – a report of an extremely rare case

34. Health status of Polish children and adolescents after cancer treatment

35. Nieprawidłowości genetyczne w ostrej białaczce szpikowej u dzieci w Polsce

36. Translocation t(8;14)(q24;q11) with concurrentPTENalterations and deletions ofSTIL/TAL1andCDKN2A/Bin a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis

38. Unsatisfactory Outcome of Pediatric Relapsed and Refractory AML Treated with Clofarabine Combined with Topotecan, Vinorelbine and Thiotepa (TVTC)

40. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland

41. Stan zdrowia i odległe następstwa transplantacji komórek krwiotwórczych u dzieci: raport Polskiej Pediatrycznej Grupy ds. Odległych Następstw Leczenia Przeciwnowotworowego.

42. LONG-TERM FOLLOW-UP OF CHILDREN AFTER ANTICANCER TREATMENT IN POLAND- STRUCTURE, PROBLEMS AND FIRST RESULTS

43. Improvement of the Treatment Results in Childhood Acute Myeloid Leukemia in Poland from 1983 to 2017

44. Improvement of the Treatment Results in Childhood Acute Myeloid Leukemia in Poland from 1983 to 2017

45. Characteristics and treatment results of refractory and relapsed acute myeloid leukaemia in paediatric patients treated in Polish Paediatric Leukaemia/Lymphoma Study Group institutions according to the Protocol Acute Myeloid Leukaemia Berlin-Frankfurt-Munster 2012 and a review of novel treatment possibilities in paediatric acute myeloid leukaemia.

46. Myeloid sarcoma in children - diagnostic and therapeutic difficulties.

Catalog

Books, media, physical & digital resources